PT73603A - Process for the preparation of solid pharmaceutical compositions containing nifedipin having an action on the blood circulation - Google Patents

Process for the preparation of solid pharmaceutical compositions containing nifedipin having an action on the blood circulation

Info

Publication number
PT73603A
PT73603A PT73603A PT7360381A PT73603A PT 73603 A PT73603 A PT 73603A PT 73603 A PT73603 A PT 73603A PT 7360381 A PT7360381 A PT 7360381A PT 73603 A PT73603 A PT 73603A
Authority
PT
Portugal
Prior art keywords
nifedipin
preparation
action
pharmaceutical compositions
compositions containing
Prior art date
Application number
PT73603A
Other languages
English (en)
Other versions
PT73603B (en
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6111496&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT73603(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of PT73603A publication Critical patent/PT73603A/pt
Publication of PT73603B publication Critical patent/PT73603B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)
PT73603A 1980-09-09 1981-08-31 Process for the preparation of solid pharmaceutical compositions containing nifedipin having an action on the blood circulation PT73603B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19803033919 DE3033919A1 (de) 1980-09-09 1980-09-09 Feste arzneizubereitungen enthaltend nifedipin und verfahren zu ihrer herstellung

Publications (2)

Publication Number Publication Date
PT73603A true PT73603A (en) 1981-09-01
PT73603B PT73603B (en) 1982-11-10

Family

ID=6111496

Family Applications (1)

Application Number Title Priority Date Filing Date
PT73603A PT73603B (en) 1980-09-09 1981-08-31 Process for the preparation of solid pharmaceutical compositions containing nifedipin having an action on the blood circulation

Country Status (20)

Country Link
EP (1) EP0047899B2 (pt)
JP (1) JPS5914446B2 (pt)
AR (1) AR226377A1 (pt)
AT (1) ATE5761T1 (pt)
AU (1) AU558331B2 (pt)
CA (1) CA1180277A (pt)
DD (1) DD201974A5 (pt)
DE (2) DE3033919A1 (pt)
DK (1) DK154326C (pt)
FI (1) FI72648B (pt)
GR (1) GR78237B (pt)
HU (1) HU184879B (pt)
IE (1) IE51549B1 (pt)
IL (1) IL63749A (pt)
NO (1) NO157368B (pt)
NZ (1) NZ198285A (pt)
PH (1) PH24097A (pt)
PL (1) PL232951A1 (pt)
PT (1) PT73603B (pt)
ZA (1) ZA816213B (pt)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5264446A (en) * 1980-09-09 1993-11-23 Bayer Aktiengesellschaft Solid medicament formulations containing nifedipine, and processes for their preparation
JPS5846019A (ja) * 1981-09-14 1983-03-17 Kanebo Ltd 持続性ニフエジピン製剤
DE3222367A1 (de) * 1982-06-15 1983-12-15 Bayer Ag, 5090 Leverkusen Verwendung von 1,4-dihydropyridinen in antiarteriosklerotika und deren herstellung
JPS59101423A (ja) * 1982-12-02 1984-06-12 Takada Seiyaku Kk 新規なニフエジピン固形製剤
US4529733A (en) * 1983-04-06 1985-07-16 Merrell Dow Pharmaceuticals Inc. Antihypertensive 3-furoyl-1,4-dihydropyridines
DE3318649A1 (de) * 1983-05-21 1984-11-22 Bayer Ag, 5090 Leverkusen Zweiphasenformulierung
NL194389C (nl) * 1984-06-14 2002-03-04 Novartis Ag Werkwijze voor het bereiden van een vaste dispersie van een farmaceutisch actief middel dat een lage oplosbaarheid in water heeft, in een vaste matrix van een in water oplosbaar polyalkyleenglycol als drager.
IT1178511B (it) * 1984-09-14 1987-09-09 Pharmatec Spa Procedimento per la preparazione di una forma solida per uso orale a base di nifedipina con rilascio
IT1187751B (it) * 1985-10-15 1987-12-23 Eurand Spa Procedimento per la preparazione di formulazioni solidi di nifedipina ad elevata biodisponibilita' e ad effetto prolungato e formulazioni cosi' ottenute
US5198226A (en) * 1986-01-30 1993-03-30 Syntex (U.S.A.) Inc. Long acting nicardipine hydrochloride formulation
US4940556A (en) * 1986-01-30 1990-07-10 Syntex (U.S.A.) Inc. Method of preparing long acting formulation
CH673947A5 (pt) * 1986-09-23 1990-04-30 Sandoz Ag
JPS6464659A (en) * 1987-09-03 1989-03-10 Kenbi Kogaku Kenkyusho Kk Preparation of safe and effective powder formulation
SE8703881D0 (sv) * 1987-10-08 1987-10-08 Haessle Ab New pharmaceutical preparation
DE3814532A1 (de) * 1988-04-29 1989-11-09 Bayer Ag Dhp-retard-zubereitung
JPH0298550U (pt) * 1989-01-25 1990-08-06
GB8903328D0 (en) * 1989-02-14 1989-04-05 Ethical Pharma Ltd Nifedipine-containing pharmaceutical compositions and process for the preparation thereof
US5271944A (en) * 1991-04-05 1993-12-21 Biofor, Ltd. Pharmacologically enhanced formulations
DE4130173A1 (de) * 1991-09-11 1993-03-18 Bayer Ag Pharmazeutische zubereitungen mit einer speziellen kristallmodifikation des 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridindicarbonsaeure-isopropyl-(2-methoxyethyl)-esters
GB9200607D0 (en) * 1992-01-13 1992-03-11 Ethical Pharma Ltd Pharmaceutical compositions containing nifedipine and process for the preparation thereof
US6726930B1 (en) 1993-09-09 2004-04-27 Penwest Pharmaceuticals Co. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5455046A (en) * 1993-09-09 1995-10-03 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5773025A (en) 1993-09-09 1998-06-30 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems--amorphous drugs
US5543099A (en) * 1994-09-29 1996-08-06 Hallmark Pharmaceutical, Inc. Process to manufacture micronized nifedipine granules for sustained release medicaments
DK0800392T3 (da) * 1994-12-29 2002-03-18 Shire Deutschland Gmbh & Co Kg Farmaceutiske præparater med indhold af nifedipin samt fremgangsmåde til fremstilling deraf
JP3220373B2 (ja) 1995-11-28 2001-10-22 バイエル薬品株式会社 持続性ニフエジピン製剤
WO1998001117A1 (en) 1996-07-08 1998-01-15 Edward Mendell Co., Inc. Sustained release matrix for high-dose insoluble drugs
IT1284604B1 (it) * 1996-09-27 1998-05-21 Roberto Valducci Composizioni farmaceutiche a rilascio controllato per somministrazione orale contenenti nifedipina come sostanza attiva
US6056977A (en) * 1997-10-15 2000-05-02 Edward Mendell Co., Inc. Once-a-day controlled release sulfonylurea formulation
IL143375A0 (en) 1999-09-30 2002-04-21 Penwest Pharmaceuticals Co Sustained release matrix systems for highly soluble drugs
EP1737847B1 (en) 2004-07-30 2008-06-04 Torrent Pharmaceuticals Ltd Nebivolol and its pharmaceutically acceptable salts, process for preparation and pharmaceutical compositions of nebivolol
DE102004062475A1 (de) * 2004-12-24 2006-07-06 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3330727A (en) * 1960-04-19 1967-07-11 Glaxo Lab Ltd Griseofulvin with high specific surface area
US3401221A (en) * 1964-08-25 1968-09-10 Norwich Pharma Co Treatment of urinary tract infection
DE2348334C2 (de) * 1973-09-26 1982-11-11 Boehringer Mannheim Gmbh, 6800 Mannheim Neue Zubereitungsform des N-4-[2-(5-Chlor-2-methoxybenzamido)äthyl]- phenyl-sulfonyl-N'-cyclohexylharnstoffs
DE2400819C2 (de) * 1974-01-09 1982-04-22 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung fester Zubereitungen von schwerlöslichen Arzneimittelwirkstoffen in feinster Verteilung
GB1579818A (en) * 1977-06-07 1980-11-26 Yamanouchi Pharma Co Ltd Nifedipine-containing solid preparation composition
JPS55129221A (en) * 1979-03-29 1980-10-06 Kaken Pharmaceut Co Ltd Preparation of oral preparation containing hardly soluble medicine
CA1146866A (en) * 1979-07-05 1983-05-24 Yamanouchi Pharmaceutical Co. Ltd. Process for the production of sustained release pharmaceutical composition of solid medical material

Also Published As

Publication number Publication date
AU558331B2 (en) 1987-01-29
IL63749A (en) 1984-06-29
ZA816213B (en) 1982-09-29
DD201974A5 (de) 1983-08-24
IE812075L (en) 1982-03-09
IL63749A0 (en) 1981-12-31
DK154326B (da) 1988-11-07
IE51549B1 (en) 1987-01-07
EP0047899B2 (de) 1996-02-28
ATE5761T1 (de) 1984-01-15
FI72648B (fi) 1987-03-31
DK154326C (da) 1995-03-13
NO812879L (no) 1982-03-10
GR78237B (pt) 1984-09-26
AU7506381A (en) 1982-03-18
AR226377A1 (es) 1982-06-30
EP0047899A1 (de) 1982-03-24
PH24097A (en) 1990-03-05
DK396381A (da) 1982-03-10
PL232951A1 (pt) 1982-10-11
DE3033919A1 (de) 1982-04-22
JPS5750913A (en) 1982-03-25
NZ198285A (en) 1984-04-27
DE3161838D1 (en) 1984-02-09
FI812758L (fi) 1982-03-10
PT73603B (en) 1982-11-10
EP0047899B1 (de) 1984-01-04
JPS5914446B2 (ja) 1984-04-04
HU184879B (en) 1984-10-29
NO157368B (no) 1987-11-30
CA1180277A (en) 1985-01-02

Similar Documents

Publication Publication Date Title
PT73603B (en) Process for the preparation of solid pharmaceutical compositions containing nifedipin having an action on the blood circulation
DE3166619D1 (en) 7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-naphthyridine-3-carboxylic acids, process for their preparation and pharmaceutical compositions containing them
PT77443A (en) Process for the preparation of pharmaceutical composition comprehending calcitonine
ZA811500B (en) Heterocyclic compounds,process for their preparation and pharmaceutical compositions containing them
DE3165428D1 (en) Substituted azobicyclooctanecarboxylic acids, process for their preparation und pharmaceutical compositions containing them
DE3162857D1 (en) Process for the preparation of carbonates
IL70520A (en) Substituted phenyl sulfonyl-oxybenzimidazolecarbamates,process for their preparation and pharmaceutical compositions containing the same
PT76870A (en) Process for the preparation of 1,4-dihydropiridine derivatives and pharmaceutical compositions containing them
DE3164697D1 (en) Process for the preparation of vinyl-stilbene compounds
DE3166538D1 (en) Novel quinoline derivatives, pharmaceutical compositions containing such compounds, and method for the preparation of these compounds
PT76426B (en) Process for preparing novel 2-beta-d-ribofuranosylselenazole-4-carboxamide compounds and of pharmaceutical compositions containing the same
PH17057A (en) Kijanimicin and salts thereof,pharmaceutical compositions containing same and process of preparring same
PT77282A (en) Process for preparing substituted 1-pyridyloxy-3-indolylalkylamino-2-propanols and of pharmaceutical compositions containing the same
EP0035820A3 (en) Novel quinoline derivatives, pharmaceutical compositions containing such compounds, and method for the preparation of these compounds
OA06939A (fr) Procédé de préparation de (trialcoxybenzyl)-1 pipérazines.
YU292582A (en) Process for obtaining laxating compounds of the senna drug
PT76951B (en) Process for the preparation of racemic or optically active eburnane-oxime derivatives and pharmaceutical compositions containing them
GB2084582B (en) Process for the preparation of acetaldehyde
DE3163621D1 (en) Process for the preparation of compounds of 2-aryloxy-2-halogen-propionic acid
DE3363148D1 (en) Process for the preparation of glycol aldehyde
IL63593A0 (en) Process for the preparation of new cytostatic compounds and pharmaceutical compositions containing them
ZA822176B (en) Pharmaceutical compositions for the treatment of diabetes
PT72338B (en) Process for the preparation of 2-aminomethyl-6-halphenols having pharmaceutical effect
DE3069793D1 (en) Method for the introduction of an oxygen-containing functional group into ansamycines, compounds thus obtained, and pharmaceutical compositions containing them
GB2080301B (en) Substituted pyrimidin-2-ones the salts thereof processes for their preparation and pharmaceutical compositions containing them